Commonly Prescribed GLP-1 Medications Two of the most widely prescribed GLP-1 receptor agonists are Ozempic and Wegovy
One literature review published in JAMA in April 2025 by a group of Irish researchers stated that GLP-1 drugs are known to reduce inflammation, improve insulin signaling, and promote neurogenesis, all of which could protect against cognitive decline. These potential benefits could also have an effect on cancer outcomes
On average, tirzepatide has been shown in research to lead to a greater amount of weight loss : People with obesity in clinical trials for tirzepatide lost, on average, 20% of their body weight at week 72 (and about 7 inches off their waistlines), compared with about 14% of their body weight (and about 5 inches off their waistlines) with semaglutide
Retatrutide acts on three hormone receptors GLP-1, GIP, and glucagon whereas Ozempic acts on GLP-1 alone
Patients should not assume retatrutide is safer or better for them simply because it targets more receptors
Get In Touch Why Researchers Choose Retatrutide Retatrutide is gaining attention for its multi-receptor activity in metabolic research, targeting GLP-1, GIP, and glucagon pathways with strong study potential
